319 related articles for article (PubMed ID: 19219089)
21. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
22. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
23. Antibiotic resistance in Latin America: a cause for alarm.
Valenzuela MT; de Quadros C
Vaccine; 2009 Aug; 27 Suppl 3():C25-8. PubMed ID: 19540634
[TBL] [Abstract][Full Text] [Related]
24. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
[TBL] [Abstract][Full Text] [Related]
25. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
Grijalva CG; Edwards KM
Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
[No Abstract] [Full Text] [Related]
26. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
[TBL] [Abstract][Full Text] [Related]
27. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
[TBL] [Abstract][Full Text] [Related]
28. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae.
McGee L
Curr Opin Microbiol; 2007 Oct; 10(5):473-8. PubMed ID: 17936680
[TBL] [Abstract][Full Text] [Related]
29. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
[TBL] [Abstract][Full Text] [Related]
30. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
Greenberg D
Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
[No Abstract] [Full Text] [Related]
31. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
Pichichero ME; Casey JR
Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
[TBL] [Abstract][Full Text] [Related]
32. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.
Temime L; Boelle PY; Opatowski L; Guillemot D
PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466
[TBL] [Abstract][Full Text] [Related]
33. Heptavalent Pneumococcal Conjugate Vaccine: growing knowledge and its implications for Italy.
Durando P; Sticchi C; Compagnino F; Ansaldi F; Sticchi L; Gasparini R; Castiglia P; Lugarini J; Alberti M; Icardi G
J Prev Med Hyg; 2008 Mar; 49(1):34-46. PubMed ID: 18792532
[No Abstract] [Full Text] [Related]
34. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.
Hausdorff WP
Vaccine; 2007 Mar; 25(13):2406-12. PubMed ID: 17055620
[TBL] [Abstract][Full Text] [Related]
35. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.
Montagnani F; Fanetti A; Stolzuoli L; Croci L; Arena F; Zanchi A; Cellesi C
J Infect; 2008 Mar; 56(3):179-84. PubMed ID: 18222005
[TBL] [Abstract][Full Text] [Related]
37. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
[TBL] [Abstract][Full Text] [Related]
38. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.
Brooks WA; Breiman RF; Goswami D; Hossain A; Alam K; Saha SK; Nahar K; Nasrin D; Ahmed N; El Arifeen S; Naheed A; Sack DA; Luby S
Am J Trop Med Hyg; 2007 Nov; 77(5):795-801. PubMed ID: 17984328
[TBL] [Abstract][Full Text] [Related]
39. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
